Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus

スポンサーリンク

概要

• 論文の詳細を見る
• 2013-06-01

著者

• MIYAGAWA JUN-ICHIRO

  Division of Diabetes & Metabolism, Internal Medicine, Hyogo College of Medicine

• Namba Mitsuyoshi

  Division Of Diabetes And Metabolism Department Of Internal Medicine Hyogo College Of Medicine

• Katsuno Tomoyuki

  Division Of Diabetes And Metabolism Department Of Internal Medicine Hyogo College Of Medicine

• IKEDA Hiroki

  Ikeda Hospital

• IDA Kenichi

  Ikeda Hospital

関連論文

• The-1535 Promoter Variant of The Visfatin Gene Is Associated with Serum Triglyceride and HDL-cholesterol Levels in Japanese Subjects
• Giant Intrasellar Arachnoid Cyst Manifesting as Adrenal Insufficiency Due to Hypothalamic Dysfunction : Case Report
• Exenatide Exhibits Dose-Dependent Effects on Glycemic Control over 12 Weeks in Japanese Patients with Suboptimally Controlled Type 2 Diabetes
• SDTラットの膵島障害進展におけるマクロファージの役割
• Effects of miglitol in combination with intensive insulin therapy on blood glucose control with special reference to incretin responses in type 1 diabetes mellitus
• The PREDICTIVE^ Study : a multinational, prospective observational study to evaluate the safety and efficacy of insulin detemir treatment in patients with type 1 and 2 diabetes-data from the Japan cohort
• International clinical harmonization of glycated hemoglobin in Japan : From Japan Diabetes Society to National Glycohemoglobin Standardization Program values
• New strategy for the treatment of type 2 diabetes mellitus with incretin-based therapy
• Add-on therapy with the DPP-4 inhibitor sitagliptin improves glycemic control in insulin-treated Japanese patients with type 2 diabetes mellitus

スポンサーリンク